01-01-1970 12:00 AM | Source: Reuters
Indian drugmaker Cipla posts 45% rise in Q1 profit on strong domestic business
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Indian pharmaceutical major Cipla reported a 45% growth in first-quarter profit on Wednesday, helped by strength in its domestic drugs business and easing input costs.
Consolidated net profit for India's third-largest drugmaker by sales climbed to 9.96 billion rupees ($121.46 million) for the quarter ended June 30 from 6.86 billion rupees a year earlier.
Analysts, on average, expected a profit of 8.36 billion rupees.
Latest News
5 big announcements from Apple's 'Let Loose' event
NSE, BSE to conduct special trading session on May 18
High possibility of 8 pc GDP growth for India in 202...
Gates Foundation-backed Axmed raises funds to help p...
India's Hero MotoCorp beats Q4 profit estimates
India received over $111 billion in remittances in 2...
M&A deals in Asia-Pacific subdued but India could bu...
L&T surges on securing multiple orders for power tra...
Crompton zooms on starting manufacturing, assembly o...
Sonata Software declines on reporting marginal fall ...
